Recording intelligenceAI-generated brief · check the source for context

TCR Signaling and T Cell Development

44:48 recording · AUTO · 2 speakers

Listen to the original

Listen to the episode
Executive Summary AI
  • Cindy Leifer records this Immune booster at the American Association of Immunologists conference in Honolulu with Leslie Berg, professor and chair at the University of Colorado School of Medicine, former AAI president and co-first editor-in-chief of ImmunoHorizons.0:53
  • Berg describes a molecular biology PhD at UC Berkeley on bovine papillomavirus, an 8KB circular DNA virus that transformed cells, before deciding with no immunology coursework to join Mark Davis' lab at Stanford, which grew from nobody to 25 people in three years while she made the TCR transgenic mice used to test positive and negative selection.3:47
  • Her first faculty job was a basic cell and molecular biology department at Harvard, chosen deliberately to avoid aggressive senior people who wanted to take her project over; a colleague down the hall who had shown SRC was a tyrosine kinase pushed her to screen for new T cell kinases beyond LCK, and after seven years she moved to the University of Massachusetts Medical School, where immunologist c8:27
  • She names her PhD advisor Mike Botchin as the biggest influence, for treating everyone who would talk science as a contributor and for dropping any hypothesis the data contradicted, and she carries that into a lab where students must be independent and where an unexpected but well-controlled result is the one that teaches something.18:06
  • Her open question is still how TCR signal strength wires different fates, which she ties to CAR T cells: 95% of pediatric ALL patients respond and only 50% still respond after more than a year, so she argues one CAR cannot make both effector and memory cells, and her advice for this moment of NIH and NSF uncertainty is not to give up.27:20

Brief overview

Leslie Berg traces molecular biology to TCR signaling, arguing signal strength should reshape CAR T cells.

  1. The people around you redirect your questionsA kinase colleague at Harvard turned a thymic selection researcher into a signaling researcher, and Berg tells junior faculty they will be doing completely different things within a year or two.
  2. Unexpected results are where learning happensIf every experiment turned out as predicted, she says, we would already know everything; a sound experiment teaches you something whether or not you like the answer.
  3. One CAR cannot make effectors and memorySince 95% of kids respond but only half hold that response past a year, she proposes splitting the transduced cells between constructs with different signaling domains.

Questions this recording answers

10 questions, each answered where it is said
Why are current CAR T cells suboptimal, according to Leslie Berg?

Berg says CAR receptors don't work like a real TCR, so the cells give unidimensional responses and can't take the heterogeneous set of fates normal T cells do. They do one thing and then drop dead. For CD19 CARs treating pediatric ALL, 95% of kids respond but only 50% keep that response beyond a year.

Answered around 29:20
How could CAR T cell therapy be improved using T cell signaling knowledge?

Berg suggests one CAR probably can't do it. Fast, aggressive effector cells kill the leukemia but don't make persistent memory cells. She proposes splitting collected T cells in half, giving each a different construct with different signaling domains, one for effectors and one for memory, mimicking strong and weak TCR signaling, then mixing them back.

Answered around 31:29
What research question does Leslie Berg's lab work on now?

Her lab still studies T cell receptor signaling: how signal strength, set by affinity or the amount of antigen on the presenting cell, steers a T cell down different differentiation paths. She wants to know the wiring inside the cell: the signaling pathways, transcription factors and gene expression programs that differ between strong and weak signaling.

Answered around 27:15
How did Leslie Berg become interested in T cell kinases and signaling?

Her first lab was in a basic cell and molecular biology department at Harvard, down the hall from a colleague who discovered that Src was a tyrosine kinase. Talking with him, she wondered what kinases T cells had, since only LCK was known, and her lab worked out a strategy to identify new tyrosine kinases.

Answered around 8:27
What did Leslie Berg work on during her PhD and postdoc?

At UC Berkeley's molecular biology PhD program she studied bovine papillomavirus, a small circular DNA virus with a roughly 8KB genome that caused cancer. Wanting to work with animals, she became an immunologist in Mark Davis's lab at Stanford, making TCR transgenic mice to see whether positive and negative selection could be observed.

Answered around 3:47
What advice does Leslie Berg give new faculty worried about differentiating from their former PI?

She tells them it won't be a problem. Within a year, at most two, they'll be doing completely different things than expected, because they get influenced by the people around them: their systems, the questions they ask, comments on their work. Put two scientists in different institutions and they inevitably end up doing different things.

Answered around 11:21
How does Leslie Berg handle students who say their experiment didn't work?

She asks what they mean, because half the time the experiment worked but didn't give the expected result. She believes a convincing, well-controlled experiment with an unexpected answer teaches you more; if every experiment turned out as predicted, we'd learn nothing. You have to believe the data rather than picking the data you like.

Answered around 22:40
What did Leslie Berg learn from her PhD advisor Mike Botchin?

Mike Botchin at Berkeley was rank agnostic, talking science for hours with anyone and valuing students' opinions, which gave her confidence she could contribute. He also formed confident hypotheses but dropped them immediately when data proved him wrong, getting even more excited to rethink. She says not clinging to ideas is a really important quality.

Answered around 18:06
What has Leslie Berg done as department chair to help faculty?

Using discretionary startup money, she hired a bioinformatics person six years ago so people could analyze RNA-seq and single-cell data for free. The department also hired a grant-writing consultant, Kim, who reads grants and critiques and advises on significance, aims and revisions. Many faculty emailed saying their grants were much better.

Answered around 40:12
What advice does Leslie Berg give trainees and early career faculty right now?

Her biggest message is don't give up. There are many obstacles, uncertainty and scary things now, but she refuses to believe US biomedical science will crash and never recover. She notes NIH has emphasized research with potential translational impact for over ten years, and justifying work by possible future applications doesn't take much.

Answered around 33:15
Key Quote

“And so for reasons that are still obscure to me and whoever, I decided to become an immunologist.”

— Leslie Berg, TCR Signaling and T Cell Development, at 5:16▶ listen at 5:16
Key Quote

“I've heard this thing about like seed and soil, right?”

— Cindy Leifer, TCR Signaling and T Cell Development, at 12:35▶ listen at 12:35
Key Quote

“You have to go, you have to believe the data.”

— Leslie Berg, TCR Signaling and T Cell Development, at 24:17▶ listen at 24:17
Key Quote

“I don't want to micromanage people's experiments.”

— Leslie Berg, TCR Signaling and T Cell Development, at 25:35▶ listen at 25:35
Key Quote

“And they suck, those things, right?”

— Leslie Berg, TCR Signaling and T Cell Development, at 29:14▶ listen at 29:14
Key Quote

“biggest message is don't give up.”

— Leslie Berg, TCR Signaling and T Cell Development, at 33:23▶ listen at 33:23

Cite this

“TCR Signaling and T Cell Development.” https://traffic.libsyn.com/secure/immune/ImmuneBooster022.mp3. Transcript summary by WhipScribe, https://whipscribe.com/transcript-pages/tcr-signaling-and-t-cell-development.html.

Report this page
What is wrong with this page?